company background image
BV3 logo

Bavarian Nordic DB:BV3 Stock Report

Last Price

€22.66

Market Cap

€1.8b

7D

0.8%

1Y

-2.7%

Updated

28 May, 2025

Data

Company Financials +

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Bavarian Nordic A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bavarian Nordic
Historical stock prices
Current Share PriceDKK 22.66
52 Week HighDKK 42.70
52 Week LowDKK 17.81
Beta1.21
1 Month Change12.35%
3 Month Change-0.18%
1 Year Change-2.75%
3 Year Change-13.84%
5 Year Change-14.30%
Change since IPO7.91%

Recent News & Updates

Recent updates

Shareholder Returns

BV3DE BiotechsDE Market
7D0.8%0.6%0.1%
1Y-2.7%-12.7%16.4%

Return vs Industry: BV3 exceeded the German Biotechs industry which returned -12.7% over the past year.

Return vs Market: BV3 underperformed the German Market which returned 16.4% over the past year.

Price Volatility

Is BV3's price volatile compared to industry and market?
BV3 volatility
BV3 Average Weekly Movement7.3%
Biotechs Industry Average Movement4.9%
Market Average Movement6.6%
10% most volatile stocks in DE Market12.9%
10% least volatile stocks in DE Market3.2%

Stable Share Price: BV3 has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: BV3's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19921,645Paul Chaplinwww.bavarian-nordic.com

Bavarian Nordic A/S develops, manufactures, and supplies life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; Vaxchora, an oral vaccine for immunization against cholera; and Vivotif/Typhoral, an oral vaccine for immunization against typhoid fever. It is also developing MVA-BN WEV for the treatment of encephalitis viruses.

Bavarian Nordic A/S Fundamentals Summary

How do Bavarian Nordic's earnings and revenue compare to its market cap?
BV3 fundamental statistics
Market cap€1.81b
Earnings (TTM)€177.19m
Revenue (TTM)€835.70m
10.2x
P/E Ratio
2.2x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BV3 income statement (TTM)
RevenueDKK 6.23b
Cost of RevenueDKK 3.00b
Gross ProfitDKK 3.23b
Other ExpensesDKK 1.91b
EarningsDKK 1.32b

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 22, 2025

Earnings per share (EPS)16.97
Gross Margin51.90%
Net Profit Margin21.20%
Debt/Equity Ratio0.1%

How did BV3 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/28 10:47
End of Day Share Price 2025/05/27 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bavarian Nordic A/S is covered by 14 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter AnkersenABG Sundal Collier
Jacob LademannCarnegie Investment Bank AB
Peter VerdultCitigroup Inc